2020 annual financial data
Ernexa Therapeutics 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was -139.67%.
Operating income was -7,248,000 USD and net income was 11,906,000 USD.
Operating cash flow was -8,101,000 USD.
Get free Ernexa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,800,000 USD
- Operating income
- -7,248,000 USD
- Net income
- 11,906,000 USD
- Operating cash flow
- -8,101,000 USD